{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-031989","form_type":"8-K","ticker":"NTLA","cik":"0001652130","company_name":"Intellia Therapeutics, Inc.","filed_at":"2025-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.316286+00:00","generated_at":"2026-05-26T06:56:59.448710+00:00","sec_items":["1.01","2.03"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Intellia signs 12-year Cambridge lease for ~147K sq ft; terminates Waltham lease with $78M payment","bullets":["New lease at 400 Technology Square, Cambridge: initial 101K sq ft, expandable to ~147K sq ft in two tranches starting Dec 2027.","Base rent $108/sq ft/year, 3% annual escalations; landlord provides up to $41.5M for tenant improvements.","Winter Street lease terminated with $78M paid in three installments (Feb 2025, Apr 2025, Jan 2026); no rent due after Jan 2025.","Lease term 12 years 3 months plus 5-year extension option; occupancy starts Jul 2025, rent begins ~14 months later."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-031989","json":"https://secwatch.observer/filing/0001193125-25-031989.json","markdown":"https://secwatch.observer/filing/0001193125-25-031989.md","text":"https://secwatch.observer/filing/0001193125-25-031989.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1652130/000119312525031989/0001193125-25-031989-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1652130/000119312525031989/d860657d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T06:56:59.448710+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}